Industry News (Joint Venture)

Agreement Provided Greater Access To Virus Inactivated Plasma Product

Published in Blood Weekly, June 8th, 1998

The American Red Cross and Blood Centers of America (BCA)/hemerica have announced the signing of an agreement to make PLAS+SD (Pooled Plasma, Solvent/Detergent Treated) available to BCA-affiliated blood centers throughout the United States.

V.I. Technologies, Inc. (VITEX) received U.S. Food and Drug Administration (FDA) licensure approval for PLAS+SD which it manufactures for the Red Cross. PLAS+SD is the first FDA-approved product to virtually eliminate specific viruses in the plasma component of the blood. The American Red Cross expected to begin product distribution during the week of May 18, 1998.

Chris Lamb, American Red Cross, said, "The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1998-06-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry